284 related articles for article (PubMed ID: 31559284)
1. Systematic review of ablative therapy for the treatment of renal allograft neoplasms.
Favi E; Raison N; Ambrogi F; Delbue S; Clementi MC; Lamperti L; Perego M; Bischeri M; Ferraresso M
World J Clin Cases; 2019 Sep; 7(17):2487-2504. PubMed ID: 31559284
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for localised renal cell carcinoma of the transplanted kidney.
Motta G; Ferraresso M; Lamperti L; Di Paolo D; Raison N; Perego M; Favi E
World J Transplant; 2020 Jun; 10(6):147-161. PubMed ID: 32742948
[TBL] [Abstract][Full Text] [Related]
3. Renal Cell Carcinoma: Alternative Nephron-Sparing Treatment Options for Small Renal Masses, a Systematic Review.
Prins FM; Kerkmeijer LGW; Pronk AA; Vonken EPA; Meijer RP; Bex A; Barendrecht MM
J Endourol; 2017 Oct; 31(10):963-975. PubMed ID: 28741377
[TBL] [Abstract][Full Text] [Related]
4. Detection and management of renal cell carcinoma in the renal allograft.
Végső G; Toronyi É; Deák PÁ; Doros A; Langer RM
Int Urol Nephrol; 2013 Feb; 45(1):93-8. PubMed ID: 22941752
[TBL] [Abstract][Full Text] [Related]
5. Trends in surgical and ablative treatment of localised renal cell carcinoma: A review of publication trends over 16 years (2000-2015).
Pietropaolo A; Jones P; Aboumarzouk OM; Rai BP; Lockyer CRW; Hayes MC; Geraghty R; Bhatnagar A; Somani BK
Arab J Urol; 2019; 17(2):120-124. PubMed ID: 31285923
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of different thermal ablative therapies for desmoid-type fibromatosis: a systematic review and meta-analysis.
Huang K; Hong R; Luo L; Zhao H; Wang Y; Li Y; Jiang Y; Zhou H; Li F
Quant Imaging Med Surg; 2023 Oct; 13(10):6683-6697. PubMed ID: 37869315
[TBL] [Abstract][Full Text] [Related]
7. Available ablation energies to treat cT1 renal cell cancer: emerging technologies.
Zondervan PJ; Buijs M; De Bruin DM; van Delden OM; Van Lienden KP
World J Urol; 2019 Mar; 37(3):445-455. PubMed ID: 30448873
[TBL] [Abstract][Full Text] [Related]
8. Local ablation of pancreatic tumors: State of the art and future perspectives.
Granata V; Grassi R; Fusco R; Belli A; Palaia R; Carrafiello G; Miele V; Grassi R; Petrillo A; Izzo F
World J Gastroenterol; 2021 Jun; 27(23):3413-3428. PubMed ID: 34163121
[TBL] [Abstract][Full Text] [Related]
9. Regular ultrasound examination of transplanted kidneys allows early diagnosis of renal cell carcinoma and conservative nephron sparing surgery.
Lentini P; Granata A; Ciancio A; Gallieni M
Arch Ital Urol Androl; 2011 Dec; 83(4):195-9. PubMed ID: 22670317
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous ultrasound-guided radiofrequency ablation of an allograft renal cell carcinoma: a case report.
Olivani A; Iaria M; Missale G; Capocasale E; Biasini E; Mazzoni MP; Lombardelli L; Luzi E; Frattini A; Pelosi G
Transplant Proc; 2011 Dec; 43(10):3997-9. PubMed ID: 22172886
[TBL] [Abstract][Full Text] [Related]
11. Cryoablation vs radiofrequency ablation for the treatment of renal cell carcinoma: a meta-analysis of case series studies.
El Dib R; Touma NJ; Kapoor A
BJU Int; 2012 Aug; 110(4):510-6. PubMed ID: 22304329
[TBL] [Abstract][Full Text] [Related]
12. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis.
Uhlig J; Strauss A; Rücker G; Seif Amir Hosseini A; Lotz J; Trojan L; Kim HS; Uhlig A
Eur Radiol; 2019 Mar; 29(3):1293-1307. PubMed ID: 30255245
[TBL] [Abstract][Full Text] [Related]
13. Focal Ablative Therapy for Renal Cell Carcinoma in Transplant Allograft Kidneys.
Gul ZG; Griffith JJ; Welch C; Fischman A; Palese MA; Badani KK; Mehrazin R
Urology; 2019 Mar; 125():118-122. PubMed ID: 30552936
[TBL] [Abstract][Full Text] [Related]
14. Harnessing the immunomodulatory effect of thermal and non-thermal ablative therapies for cancer treatment.
Bastianpillai C; Petrides N; Shah T; Guillaumier S; Ahmed HU; Arya M
Tumour Biol; 2015 Dec; 36(12):9137-46. PubMed ID: 26423402
[TBL] [Abstract][Full Text] [Related]
15. Current and future technology for minimally invasive ablation of renal cell carcinoma.
Duffey BG; Kyle Anderson J
Indian J Urol; 2010 Jul; 26(3):410-7. PubMed ID: 21116364
[TBL] [Abstract][Full Text] [Related]
16. Solid Renal Masses in Transplanted Allograft Kidneys: A Closer Look at the Epidemiology and Management.
Griffith JJ; Amin KA; Waingankar N; Lerner SM; Delaney V; Ames SA; Badani K; Palese MA; Mehrazin R
Am J Transplant; 2017 Nov; 17(11):2775-2781. PubMed ID: 28544435
[TBL] [Abstract][Full Text] [Related]
17. Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.
Forauer AR; Dewey BJ; Seigne JD
Urol Oncol; 2014 Aug; 32(6):869-76. PubMed ID: 24946958
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive therapy of incidental de novo renal cell carcinoma in a kidney allograft 12 years after transplantation: report of a case and review of literature.
Matevossian E; Novotny A; Vogelsang B; Mehler J; Stangl M; Thorban S; Dobritz M
Transplant Proc; 2008 May; 40(4):915-7. PubMed ID: 18555077
[TBL] [Abstract][Full Text] [Related]
19. Thermal ablation of pancreatic cancer: A systematic literature review of clinical practice and pre-clinical studies.
Saccomandi P; Lapergola A; Longo F; Schena E; Quero G
Int J Hyperthermia; 2018; 35(1):398-418. PubMed ID: 30428728
[TBL] [Abstract][Full Text] [Related]
20. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy.
Aron M; Gill IS
Eur Urol; 2007 Feb; 51(2):348-57. PubMed ID: 17084513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
